Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Almaject® is focused on the development, acquisition, and commercialization of injectable generic pharmaceutical products. The current portfolio of injectables covers a broad range of therapeutic areas. Our commercial, business development, and R&D teams are creating new opportunities to expand our portfolio into complex molecules. Almaject is a US subsidiary of Alvogen. The parent company Alvogen, is a global, privately owne...
Almaject® is focused on the development, acquisition, and commercialization of injectable generic pharmaceutical products. The current portfolio of injectables covers a broad range of therapeutic areas. Our commercial, business development, and R&D teams are creating new opportunities to expand our portfolio into complex molecules. Almaject is a US subsidiary of Alvogen. The parent company Alvogen, is a global, privately owned pharmaceutical company focused on the development, manufacturing and commercialization of generic, brand, OTC and biosimilar products around the world.

List your booth number for exhibitions, ask us